These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6453435)

  • 21. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
    Ofosu FA
    Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of rat skin heparin chains with high affinity for antithrombin.
    Horner AA
    Biochem J; 1987 Jun; 244(3):693-8. PubMed ID: 3446185
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of affinity and structural selectivity in the binding of proteins to glycosaminoglycans: development of a sensitive electrophoretic approach.
    Lee MK; Lander AD
    Proc Natl Acad Sci U S A; 1991 Apr; 88(7):2768-72. PubMed ID: 1901416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Generation of affinity for antithrombin III by supplemental sulfation of heparin species with low affinity for the protein.
    Ogamo A; Metori A; Uchiyama H; Nagasawa K
    J Biochem; 1990 Oct; 108(4):588-92. PubMed ID: 2292586
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fractionation of heparin, dermatan sulfate, and chondroitin sulfate by sequential precipitation: a method to purify a single glycosaminoglycan species from a mixture.
    Volpi N
    Anal Biochem; 1994 May; 218(2):382-91. PubMed ID: 8074297
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Binding of anti-prion agents to glycosaminoglycans: evidence from electronic absorption and circular dichroism spectroscopy.
    Zsila F; Gedeon G
    Biochem Biophys Res Commun; 2006 Aug; 346(4):1267-74. PubMed ID: 16793017
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of sulfation on the anticoagulant and antithrombin III-binding properties of a heparin fraction with low affinity for antithrombin III.
    Schoen P; Wielders S; Petitou M; Lindhout T
    Thromb Res; 1990 Feb; 57(3):415-23. PubMed ID: 2315894
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of the strength of binding of antithrombin III, protamine and poly(L-lysine) to heparin samples of different anticoagulant activities.
    Jones GR; Hashim R; Power DM
    Biochim Biophys Acta; 1986 Aug; 883(1):69-76. PubMed ID: 3730427
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-affinity material does not contribute to the antithrombotic activity of Orgaran (Org 10172) in human plasma.
    Zammit A; Dawes J
    Thromb Haemost; 1994 Jun; 71(6):759-67. PubMed ID: 7526481
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heparin with low affinity to antithrombin III inhibits the activation of prothrombin in normal plasma.
    Ofosu FA; Modi G; Cerskus AL; Hirsh J; Blajchman MA
    Thromb Res; 1982 Nov; 28(4):487-97. PubMed ID: 7164033
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nature of the anti-Xa activity induced by a heparin analogue (SSHA) in vivo.
    Schmitz-Huebner U; Lobreyer EM; van de Loo J
    Thromb Res; 1982 Sep; 27(6):757-62. PubMed ID: 6817453
    [No Abstract]   [Full Text] [Related]  

  • 32. Fractionation of heparin by chromatography on immobilized thrombin. Correlation between the anticoagulant activity of the fractions and their content of heparin with high affinity for antithrombin.
    Nordenman B; Björk I
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):711-8. PubMed ID: 7444870
    [No Abstract]   [Full Text] [Related]  

  • 33. Biologic actions of heparin.
    Rosenberg RD
    Semin Hematol; 1977 Oct; 14(4):427-40. PubMed ID: 144323
    [No Abstract]   [Full Text] [Related]  

  • 34. Anticoagulant effect of unfractionated heparin in antithrombin-depleted plasma in vitro.
    Krulder JW; Strebus AF; Meinders AE; Briët E
    Haemostasis; 1996; 26(2):85-9. PubMed ID: 9119287
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overlapping sites on the Link module of human TSG-6 mediate binding to hyaluronan and chrondroitin-4-sulphate.
    Parkar AA; Day AJ
    FEBS Lett; 1997 Jun; 410(2-3):413-7. PubMed ID: 9237673
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The degradation of hyaluronate, the chondroitin sulfates and heparin by bacterial enzymes (flavobacterium).
    HOFFMAN P; LINKER A; SAMPSON P; MEYER K; KORN ED
    Biochim Biophys Acta; 1957 Sep; 25(3):658-9. PubMed ID: 13479448
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of heparin on the vascular distribution of *I-antithrombin III isoforms in rabbits.
    Carlson TH
    Thromb Res; 1989 Aug; 55(4):471-80. PubMed ID: 2814938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heparin and heparan sulfate binding sites on B-16 melanoma cells.
    Biswas C
    J Cell Physiol; 1988 Jul; 136(1):147-53. PubMed ID: 2840440
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition by heparin-modulated antithrombin III of amidolysis catalysed by m beta-acrosin.
    Long WF; Williamson FB
    Biochem J; 1984 Feb; 217(3):721-5. PubMed ID: 6231919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.